Royce & Associates’s Emergent Biosolutions EBS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-178,676	Closed	-$7.34M	–	948
2022 Q1	$7.34M	Buy	178,676 +2,120	+1%	+$93.5K	0.06%	456
2021 Q4	$7.67M	Sell	176,556 -59,275	-25%	-$2.68M	0.06%	461
2021 Q3	$11.8M	Buy	235,831 +941	+0.4%	+$57K	0.09%	358
2021 Q2	$14.8M	Sell	234,890 -2,271	-1%	-$146K	0.1%	337
2021 Q1	$22M	Buy	237,161 +53,579	+29%	+$5.49M	0.15%	218
2020 Q4	$16.4M	Buy	183,582 +68,017	+59%	+$6.24M	0.14%	227
2020 Q3	$11.9M	Sell	115,565 -63,429	-35%	-$6.84M	0.13%	234
2020 Q2	$14.2M	Sell	178,994 -22,000	-11%	-$1.64M	0.16%	176
2020 Q1	$11.6M	Sell	200,994 -115,933	-37%	-$6.68M	0.16%	176
2019 Q4	$17.1M	Buy	316,927 +17,419	+6%	+$945K	0.15%	179
2019 Q3	$15.7M	Buy	299,508 +58,644	+24%	+$2.73M	0.14%	200
2019 Q2	$11.6M	Buy	240,864 +235,230	+4,175%	+$11.3M	0.11%	281
2019 Q1	$285K	Buy	+5,634	New	+$332K	﹤0.01%	973
2018 Q4	–	Sell	-559	Closed	-$37K	–	1164
2018 Q3	$37K	Buy	559 +195	+54%	+$11.4K	﹤0.01%	1067
2018 Q2	$18K	Buy	364 +152	+72%	+$7.92K	﹤0.01%	1140
2018 Q1	$11K	Sell	212 -20	-9%	-$997	﹤0.01%	1162
2017 Q4	$11K	Sell	232 -26	-10%	-$1.09K	﹤0.01%	1165
2017 Q3	$10K	Buy	+258	New	+$9.34K	﹤0.01%	1163
2013 Q3	–	Sell	-30,386	Closed	-$438K	–	1453
2013 Q2	$438K	Buy	+30,386	New	+$440K	﹤0.01%	1244